Global Contraceptive Devices Market - 2025-2033

The global contraceptive devices market reached US$ 10.98 billion in 2024 and is expected to reach US$ 19.37 billion by 2033, growing at a CAGR of 6.6% during the forecast period of 2025-2033.

Contraceptive devices are physical products designed to prevent pregnancy by either obstructing sperm from reaching an egg or altering the body's hormonal or physical environment to make pregnancy less likely. These devices come in various forms and can be used by both men and women. They are one of the most common methods of birth control, alongside hormonal methods like pills or injections. Contraceptive devices provide a critical solution in family planning, reproductive health, and population control.

The demand for contraceptive devices has been steadily increasing worldwide, driven by a combination of demographic, social, economic, and healthcare-related factors. This growing demand is primarily influenced by the desire for better family planning, more effective control over reproduction, increasing awareness of sexual health, and novel product launches. For instance, in September 2024, ConTIPI Medical partnered with EVERSANA to support the US commercial launch of the ProVate device.

Market Dynamics: Drivers & Restraints

Rising Awareness and Government Initiatives

The rising awareness and government initiatives are significantly driving the growth of the contraceptive devices market and are expected to drive the market over the forecast period. Governments worldwide are prioritizing family planning as a key aspect of public health, recognizing that it has a direct impact on economic development, healthcare costs, and gender equality. Many countries have launched national family planning programs that make contraceptive devices more accessible and affordable to a broad population.

For instance, the National Family Planning Program in India has been a cornerstone of the country's contraceptive distribution efforts. India aims to reduce its population growth rate, and through government subsidies and awareness campaigns, millions of people have been introduced to modern contraceptive methods. In 2020, India saw an increase in the use of long-acting reversible contraceptives (LARCs) such as IUDs and implants.

Awareness campaigns, whether spearheaded by governments or NGOs, have brought crucial information about contraceptive methods to a wide range of people, particularly in underserved and rural areas. These initiatives emphasize the benefits of contraceptive devices and provide accurate information to combat myths and misinformation about contraception. By educating the public, particularly young people and women, governments and organizations are removing barriers to contraceptive use, leading to higher demand.

For instance, in countries like the United States, organizations like Planned Parenthood run education programs to raise awareness about contraceptive methods. These programs aim to equip individuals with information on their reproductive health options, thus increasing the adoption of contraceptive methods. In 2021, over 2.4 million people in the U.S. used contraceptive services provided by Planned Parenthood, illustrating the effectiveness of awareness programs.

Side Effects and Health Concerns

While contraceptive devices offer significant benefits in terms of preventing pregnancy and controlling reproduction, side effects and health concerns remain key factors that can hamper market growth. These concerns often lead to hesitancy in using certain methods and can even result in discontinuation after initial use, limiting their overall adoption and market expansion.

Many popular contraceptive devices, particularly hormonal options like IUDs (intrauterine devices), implants, and vaginal rings, release hormones into the body. While these methods are highly effective in preventing pregnancy, they often come with a range of side effects that deter users from continued use. However, there are associated risks of infection and uterine perforation upon insertion, especially if not performed in a sterile environment or by trained healthcare professionals.

Some individuals are concerned about the long-term impact of hormonal contraceptive methods on their health, including fertility issues or increased cancer risk. There are fears that the use of hormonal devices like implants or IUDs may reduce fertility or delay the return to normal fertility after stopping use. However, these concerns are often based on misinformation or outdated studies.

Segment Analysis

The global contraceptive devices market is segmented based on product type, technology, gender, distribution channel, and region.

Product Type:

The condoms is expected to dominate in the product type segment of contraceptive devices market with the share.

The condoms segment holds a dominant position in the global contraceptive devices market due to several factors, including affordability, ease of use, dual protection against both pregnancy and sexually transmitted infections (STIs), and wide availability. The combination of these factors has made condoms the most widely used form of contraception worldwide.

One of the most significant reasons for the dominance of condoms is that they provide dual protection against both pregnancy and sexually transmitted infections (STIs). Unlike other contraceptive methods, such as IUDs or hormonal contraceptives, condoms are the only method that also helps prevent the transmission of diseases like HIV, chlamydia, and gonorrhea. This makes condoms particularly popular in regions with high rates of STIs.

For instance, according to the World Health Organization, 374 million new STI infections occurred globally among adults aged 15-49 with 1 of the 4 curable STIs: syphilis, chlamydia, gonorrhea, and trichomoniasis. Most of these could be prevented with the correct use of condoms.

Condoms are low-cost compared to other contraceptive methods, which makes them highly accessible to a wide demographic, including low-income populations. Many countries offer free or subsidized condoms through public health initiatives, making them available to even those in remote or underserved areas. The wide availability, coupled with affordability, has made condoms the most used method of contraception globally.

Geographical Analysis

North America is expected to hold a significant position in the contraceptive devices market with the highest market share

North America boasts one of the highest levels of awareness and education about family planning and sexual health globally. Comprehensive sex education programs, particularly in the U.S. and Canada, ensure that individuals have a clear understanding of contraception methods, their benefits, and their side effects. This has led to the widespread acceptance and use of various contraceptive devices.

For instance, according to the Guttmacher Institute, 99% of women aged 15-44 in the U.S. who have had sex have used at least one contraceptive method, with 75% of them using modern methods like IUDs, implants, and condoms. The high level of awareness about birth control options directly drives demand for contraceptive devices.

Governments in North America actively promote family planning and reproductive health through subsidies, awareness campaigns, and public health programs. These initiatives play a critical role in ensuring that contraceptive devices are accessible and affordable for a broad population. For instance, the United States government supports family planning through federal programs like Title X, which provides funding for family planning clinics.

Asia-Pacific is growing at the fastest pace in the contraceptive devices market

The Asia-Pacific region has the largest population in the world, with over 4.6 billion people, representing about 60% of the global population. This vast population, especially in countries like India and China, creates a substantial demand for family planning solutions and contraceptive methods. As the population continues to grow, governments and individuals are increasingly turning to contraception to control family sizes and improve reproductive health.

For instance, with a population exceeding 1.4 billion people, India is one of the world's most populous countries, and the demand for contraceptives is increasing as families seek to manage the birth rate. According to the National Family Health Survey (NFHS), over 50% of married women in India use modern contraceptive methods, with a significant portion opting for IUDs, condoms, and oral contraceptive pills. India's government has actively promoted family planning through programs like Mission Parivar Vikas, aiming to increase contraceptive prevalence.

Governments in the Asia-Pacific region play a critical role in promoting family planning and contraceptive use through policies and financial support. Many countries have established national programs to distribute contraceptive devices, reduce birth rates, and improve maternal health. This government backing has directly contributed to the growing contraceptive market. For instance, India has consistently emphasized family planning in its national policies, and its National Family Planning Program has expanded access to free or subsidized contraceptives across the country. This has led to a rise in the use of IUDs, oral contraceptives, and sterilization methods.

Competitive Landscape

The major global players in the contraceptive devices market include CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group, Veru Inc., Bayer AG, Abbvie Inc., EUROGINE, S.L., Mona Lisa N.V., Prosan International BV, and OCON Medical Ltd., among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global contraceptive devices market report delivers a detailed analysis with 70 key tables, more than 64 visually impactful figures, and 163 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.